Literature DB >> 4039014

Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations.

T W Jones, S Chopra, J S Kaufman, W Flamenbaum, B F Trump.   

Abstract

Studies were undertaken to examine the relationship between renal morphologic and functional alterations during the development of cis-diamminedichloroplatinum (II) (CDDP)-induced acute renal failure (ARF). Control and CDDP-treated rats (10 mg/kg, intraperitoneally) were housed in metabolic cages for the purpose of renal function determinations. Renal morphology was studied by light and electron microscopy at 6, 24, 48, 72, and 96 hours following treatment. Six hours following CDDP administration, morphologic alterations consisting of nucleolar segregation, ribosome dispersion, and the formation of aggregates of smooth endoplasmic reticulum were observed throughout the P3 portion of the proximal tubule located in the outer stripe of the outer medulla and medullary rays. These changes became more frequently observed throughout P3 during the course of the study. At 24 and 48 hours, focal changes were also observed involving the P1 and P2 segments of the proximal tubule which make up the pars convoluta. ARF, indicated by a reduced creatinine clearance, was first apparent 48 hours following CDDP administration. The development of ARF was associated with focal, primarily sublethal, cell injury throughout the proximal tubule. By 72 and 96 hours necrosis primarily affecting P3 became widespread, and renal function progressively worsened. The establishment of ARF prior to the development of tubular necrosis suggests that the processes of tubular obstruction and/or tubular fluid backleak are not involved in the initiation of ARF in this model. Instead, the alterations involving P1 and P2 appear to be most important during the early stages of CDDP-induced ARF. The severity of the convoluted tubular injury at 48 hours showed a significant correlation with the degree of renal function impairment. The tubular injury affecting P3 did not correlate with the loss of renal function at any of the time points studied. However, tubular injury in P3 did appear responsible for some degree of renal function impairment at 72 and 96 hours, probably as a result of tubular obstruction and/or tubular fluid backleak.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039014

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662

2.  An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.

Authors:  C Ewen; A Perera; J H Hendry; C A McAuliffe; H Sharma; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure.

Authors:  Min Li; Saravanan Balamuthusamy; Altaf M Khan; Jerome L Maderdrut; Eric E Simon; Vecihi Batuman
Journal:  J Mol Neurosci       Date:  2010-06-01       Impact factor: 3.444

4.  Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin.

Authors:  Suayib Yalcin; Sevda Müftüoğlu; Eren Cetin; Banu Sarer; Berna Akkuş Yildirim; Dilara Zeybek; Bülent Orhan
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration.

Authors:  I A Atencio; F F Shadan; X J Zhou; N D Vaziri; L P Villarreal
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats.

Authors:  C Orfila; G Bompart; J C Lepert; J M Suc; J P Girolami
Journal:  Histochem J       Date:  1993-10

7.  Accumulation of platinum in the intervertebral discs and vertebrae of ovarian tumor-bearing patients treated with cisplatin.

Authors:  T Minami; K Hashii; I Tateyama; E Kadota; Y Tohno; S Tohno; M Utsumi; M O Yamada; M Ichii; K Namikawa
Journal:  Biol Trace Elem Res       Date:  1994-09       Impact factor: 3.738

8.  A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat.

Authors:  I Mahmood; D H Waters
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

9.  The interaction of platinum antitumour drugs with mouse liver mitochondria.

Authors:  M Rosen; M Figliomeni; H Simpkins
Journal:  Int J Exp Pathol       Date:  1992-02       Impact factor: 1.925

10.  The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.

Authors:  M M Jones; M A Basinger; J A Beaty; M A Holscher
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.